Patent ID: 9057731
Filing Date: 2015-06-16
Classification: G01N

Abstract:
1. A method for predicting a response that a subject to be administered an erythropoietic agent would have to the administered erythropoietic agent, the method comprising: (a) providing a serum sample from the subject; (b) measuring an amount in the sample of the peptide consisting of SEQ ID NO: 13; (c) comparing the amount of the peptide in the sample to a control level of the peptide; (d) predicting that the subject will have a good response to the erythropoietic agent when there is a measurable increase in the amount of the peptide consisting of SEQ ID NO: 13 in the sample as compared to the control level; and (e) administering an amount of the erythropoietic agent to the subject based on the results of the predicting step (d), wherein a differing amount of the erythropoietic agent is administered when the subject is predicted to have a good response relative to the amount of the erythropoietic agent administered when the subject is not predicted to have a good response.